Impact of Probiotics on Risk Factors for Cardiovascular Diseases. A Review

Critical Reviews in Food Science and Nutrition

Volumn 54, Issue 2, 2014, Pages 175-189

  Ebel, Bruno ^a,b   Lemetais, Guillaume ^a,c   Beney, Laurent ^a   Cachon, Rémy ^a   Sokol, Harry ^d,e   Langella, Philippe ^d   Gervais, Patrick ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b Senoble Holding   (France)

^c Merck Medication Familiale   (France)

^d UMR1319 MICALIS   (France)

^e SORBONNE UNIVERSITÉ   (France)

Author keywords

cardiovascular disease; cholesterol; lipid metabolism; obesity; oxidative stress; Probiotic bacteria; review

Indexed keywords

ARTERIAL HYPERTENSION; CARDIO-VASCULAR DISEASE; GASTROINTESTINAL DISORDERS; HYPERCHOLESTEROLEMIA; INFLAMMATORY BOWEL DISEASE; LIPID METABOLISMS; OBESITY; PROBIOTIC BACTERIA;

CHOLESTEROL; METABOLISM; NUTRITION; OXIDATIVE STRESS; REVIEWS;

DISEASES;

ENZYME; PROBIOTIC AGENT;

ANIMAL; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; IMMUNITY; INTESTINE; LIPID METABOLISM; MICROBIOLOGY; MICROFLORA; OBESITY; OXIDATIVE STRESS; REVIEW; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; ENZYMES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; IMMUNITY; INTESTINES; LIPID METABOLISM; MICROBIOTA; OBESITY; OXIDATIVE STRESS; PROBIOTICS; RISK FACTORS;

EID: 84887123338     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2011.579361     Document Type: Review

References (183)

1. Agerholm-Larsen, L., Bell, L., Grunwald, G. and Astrup, A. 2000. The effect of a probiotic milk product on plasma cholesterol: A meta-analysis of short-term intervention studies. Eur. J. Clin. Nutr., 54: 856-860.
2. Agrawal, A., Houghton, L. A., Morris, J., Guyonnet, D., Goupil Feuillerat, N., Schlumberger, A., Jakob, S. and Whorwell, P. J. 2008. Fermented milk containing the probiotic Bifidobacterium animalis, DN-173 010 (FM) improves abdominal distension, bloating and transit in irritable bowel syndrome with constipation (IBS-C). Gastroenterology., 134 (4): A-546.
3. Aihara, K., Kajimoto, O., Hirata, H., Takahashi, R. and Nakamura, Y. 2005. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J. Am. Coll. Nutr., 24 (4): 257-265.
4. Ait-Belgnaoui, A., Han, W., Lamine, F., Eutamene, H., Fioramonti, J., Bueno, L. and Theodorou, V. 2006. Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: A possible action through interaction with epithelial cell cytoskeleton contraction. Gut., 55 (8): 1090-1094.
5. Akalin, A. S., Tokusoglu, O., Gonc, S. and Aycan, S. 2007. Occurrence of conjugated linoleic acid in probiotic yoghurts supplemented with fructooligosaccharide. Int. Dairy J., 17 (9): 1089-1095.
6. Ali, A. A., Velasquez, M. T., Hansen, C. T., Mohamed, A. I. and Bhathena, S. J. 2004. Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J. Nutr. Biochem., 15 (10): 583-590.
7. Andrade, S. and Borges, N. 2009. Effect of fermented milk containing Lactobacillus acidophilus and Bifidobacterium longum on plasma lipids of women with normal or moderately elevated cholesterol. J. Dairy Res., 76 (04): 469-474.
8. Ataie-Jafari, A., Larijani, B., Majd, H. A. and Tahbaz, F. 2009. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann. Nutr. Metab., 54: 22-27.
9. Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F. and Gordon, J. I. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci., 101 (44): 15718-15723.
10. Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. and Gordon, J. I. 2005. Host-bacterial mutualism in the human intestine. Science., 307 (5717): 1915-1920.
11. Baker, H. and Day, B. 2008. Probiotics: Where are they going next? New and emerging areas of research. Nutr. Bull., 33 (4): 359-363.
12. Banday, A. A. and Lokhandwala, M. F. 2011. Oxidative stress causes renal angiotensin II Type 1 receptor upregulation, Na+/H+ exchanger 3 overstimulation, and hypertension. Hypertension., 57 (3): 452-459.
13. Bean, H., Radu, F., De, E., Schuler, C., Leggett, R. and Levin, R. 2009a. Comparative evaluation of antioxidant reactivity within obstructed and control rabbit urinary bladder tissue using FRAP and CUPRAC assays. Mol. Cell Biochem., 323 (1): 139-142.
14. Bean, H., Schuler, C., Leggett, R. and Levin, R. 2009b. Antioxidant levels of common fruits, vegetables, and juices versus protective activity against in vitro ischemia/reperfusion. Int. Urol. Nephrol., 42 (2): 409-415.
15. Begley, M., Gahan, C. G. M. and Hill, C. 2005. The interaction between bacteria and bile. FEMS Microbiol. Rev., 29 (4): 625-651.
16. Bermudez-Humaran, L. G., Nouaille, S., Zilberfarb, V., Corthier, G., Gruss, A., Langella, P. and Issad, T. 2007. Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice. Appl. Environ. Microbiol., 73 (16): 5300-5307.
17. Besnard, P., Poirier, H., Niot, I. and Guerre-Millo, M. 2005. CLA, new nutrients?. Med. Nutr., 41 (2): 63-68.
18. Betoret, N., Puente, L., Díaz, M. J., Pagán, M. J., García, M. J., Gras, M. L., Martínez-Monzó, J. and Fito, P. 2003. Development of probiotic-enriched dried fruits by vacuum impregnation. J. Food Eng., 56 (2-3): 273-277.
19. Burnier, M. and Zanchi, A. 2006. Blockade of the renin-angiotensin-aldosterone system: A key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes. J. Hypertens., 24 (1): 11-25.
20. Cani, P. D. and Delzenne, N. M. 2009. Interplay between obesity and associated metabolic disorders: New insights into the gut microbiota. Curr. Opin. Pharmacol., 9 (6): 737-743.
21. Cani, P. D. and Delzenne, N. M. (2011). The gut microbiome as therapeutic target. Pharmacol. Ther., 130 (2): 202-212.
22. Cani, P., Neyrinck, A., Fava, F., Knauf, C., Burcelin, R., Tuohy, K., Gibson, G. and Delzenne, N. 2007. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia., 50 (11): 2374-2383.
23. Cardona, M. E., de, V. V. V., Midtvedt, T. and Norin, K. E. 2000. Probiotics in gnotobiotic mice conversion of cholesterol to coprostanol in vitro and in vivo and bile acid deconjugation in vitro. Microb. Ecol. Health Dis., 12: 219-224.
24. Caropreso, M., Lenta, S., Passaretti, M., Colicchio, P., Mandato, C., Capuano, G., Franzese, A., Spagnuolo, M. I. and Vajro, P. 2006. Lactobacillus rhamnosus GG treatment: A promising tool for improving hypertransaminasemia of obese children. Digest. Liver Dis., 38 (10): A89
25. Castellani, R. J., Lee, H. G., Zhu, X., Perry, G. and Smith, M. A. 2008. Alzheimer disease pathology as a host response. J. Neuropathol. Exp. Neurol., 67 (6): 523-31.
26. Chiu, C. H., Lu, T. Y., Tseng, Y. Y. and Pan, T. M. 2006. The effects of Lactobacillus-fermented milk on lipid metabolism in hamsters fed on high-cholesterol diet. Appl. Microbiol. Biot., 71 (2): 238-245.
27. Collado, M., Grześkowiak, Ł. and Salminen, S. 2007. Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa. Curr. Microbiol., 55 (3): 260-265.
28. Corr, S. a. C., Li, Y., Riedel, C. U., O'Toole, P. W., Hill, C. and Gahan, C. G. M. 2007. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci., 104 (18): 7617-7621.
29. Corthesy, B., Gaskins, H. R. and Mercenier, A. 2007. Cross-talk between probiotic bacteria and the host immune system. J. Nutr., 137 (3): 781S-790S.
30. Crittenden, R. G., Martinez, N. R. and Playne, M. J. 2003. Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteria. Int. J. Food Microbiol., 80 (3): 217-222.
31. Dacosta, Y. 2001. Probiotiques et Prébiotiques en Alimentation Humaine. Le Point sur les Connaissances Actuelles, Lavoisier, Paris: Tec & Doc Diffusion.
32. Dave, R. I. and Shah, N. P. 1997. Effectiveness of ascorbic acid as an oxygen scavenger in improving viability of probiotic bacteria in yoghurts made with commercial starter cultures. Int. Dairy J., 7 (6-7): 435-443.
33. Delzenne, N. and Reid, G. 2009. No causal link between obesity and probiotics. Nat. Rev. Micro., 7 (12): 901-901.
34. de Vrese, M., Stegelmann, A., Richter, B., Fenselau, S., Laue, C. and Schrezenmeir, J. 2001. Probiotics-compensation for lactase insufficiency. Am. J. Clin. Nutr., 73 (2): 421S-429S.
35. DiBaise, J. K., Zhang, H., Crowell, M. D., Krajmalnik-Brown, R., Decker, G. A. and Rittmann, B. E. 2008. Gut microbiota and its possible relationship with obesity. Mayo. Clin. Proc., 83 (4): 460-469.
36. Dinavahi, R. and Falkner, B. 2004. Relationship of homocysteine with cardiovascular disease and blood pressure. J. Clin. Hypertens., 6 (9): 494-498.
37. Dominguez-Bello, M. G. and Blaser, M. J. 2008. Do you have a probiotic in your future?. Microbes. Infect., 10 (9): 1072-1076.
38. Donkor, O. N., Henriksson, A., Singh, T. K., Vasiljevic, T. and Shah, N. P. 2007. ACE-inhibitory activity of probiotic yoghurt. Int. Dairy J., 17 (11): 1321-1331.
39. Drouault, S., Juste, C., Marteau, P., Renault, P. and Corthier, G. 2002. Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency. Appl. Environ. Microbiol., 68 (6): 3166-3168.
40. Durrington, P. 2003. Dyslipidaemia. Lancet., 362 (9385): 717-731.
41. D'Souza, A., Fordjour, L., Ahmad, A., Cai, C., Kumar, D., Valencia, G., Aranda, J. V. and Beharry, K. D. 2010. Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of Caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr. Res., 67 (5): 526-531.
42. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E. and Relman, D. A. 2005. Diversity of the human intestinal microbial flora. Science., 308 (5728): 1635-1638.
43. Eckel, R. H., Grundy, S. M. and Zimmet, P. Z. 2005. The metabolic syndrome. Lancet., 365 (9468): 1415-1428.
44. Erkkilä, S., Petäjä, E., Eerola, S., Lilleberg, L., Mattila-Sandholm, T. and Suihko, M. L. 2001. Flavour profiles of dry sausages fermented by selected novel meat starter cultures. Meat Sci., 58 (2): 111-116.
45. Fabian, E. and Elmadfa, I. 2007. The effect of daily consumption of probiotic and conventional yoghurt on oxidant and anti-oxidant parameters in plasma of young healthy women. Int. J. Vitamin Nutr. Res., 77 (2): 79-88.
46. Fabian, E., Majchrzak, D., Dieminger, B., Meyer, E. and Elmadfa, I. 2008. Influence of probiotic and conventional yoghurt on the status of vitamins B1, B2 and B6 in young healthy women. Ann. Nutr. Metab., 52 (1): 29-36.
47. FAO/WHO. 2002. " Guidelines for the evaluation of probiotics in food in Report of a Joint FAO/WHO ". In Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, Edited by: Ontario, C. London, Ontario, Canada: Food and Agriculture and World Health Organization.
48. Flambard, B. 2002. Role of bacterial cell wall proteinase in antihypertension. Sci Aliment., 22 (1): 209-222.
49. Flier, J. S. and Mekalanos, J. J. 2009. Gut check: Testing a role for the intestinal microbiome in human obesity. Sci. Transl. Med., 1 (6): 6ps7
50. Fridovich, I. 1998. Oxygen toxicity: A radical explanation. J. Exp. Biol., 201 (8): 1203-1209.
51. Fukushima, M. and Nakano, M. 1996. Effects of a mixture of organisms, Lactobacillus acidophilus or Streptococcus faecalis on cholesterol metabolism in rats fed on a fat- and cholesterol-enriched diet. Br. J. Nutr., 76 (6): 857-867.
52. Fuller, R. 1991. Probiotics in human medicine. Gut., 32 (4): 439-442.
53. Gainer, J. V., Morrow, J. D., Loveland, A., King, D. J. and Brown, N. J. 1998. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl. J. Med., 339 (18): 1285-1292.
54. Gardiner, G., Ross, R. P., Collins, J. K., Fitzgerald, G. and Stanton, C. 1998. Development of a probiotic cheddar cheese containing human-derived Lactobacillus paracasei strains. Appl. Environ. Microbiol., 64 (6): 2192-2199.
55. Gerard, P., Lepercq, P., Leclerc, M., Gavini, F., Raibaud, P. and Juste, C. 2007. Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces. Appl. Environ. Microbiol., 73 (18): 5742-5749.
56. Gilliland, S. E. and Walker, D. K. 1990. Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans. J. Dairy Sci., 73 (4): 905-911.
57. Girard, S. A., Bah, T. M., Kaloustian, S., Lada-Moldovan, L., Rondeau, I., Tompkins, T. A., Godbout, R. and Rousseau, G. 2009. Lactobacillus helveticus and Bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Br. J. Nutr., 102 (10): 1420-1425.
58. Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S. and Tyroler, H. A. 1989. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation., 79 (1): 8-15.
59. Griendling, K. K. and FitzGerald, G. A. 2003a. Oxidative stress and cardiovascular injury: Part I: Basic mechanisms and in vivo monitoring of ROS. Circulation., 108 (16): 1912-1916.
60. Griendling, K. K. and FitzGerald, G. A. 2003b. Oxidative stress and cardiovascular injury: Part II: Animal and human studies. Circulation., 108 (17): 2034-2040.
61. Grundy, S. M., Brewer, H. B. Jr., Cleeman, J. I., Smith, S. C. Jr., Lenfant, C. and National Heart, Lung, and Blood Institute; AmericanHeartAssociation. 2004. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation., 109 (3): 433-438.
62. Guslandi, M., Mezzi, G., Sorghi, M. and Testoni, P. A. 2000. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci., 45: 1462-1464.
63. Han, W. and Fioramonti, J. 2008. Anti-inflammatory properties of lactic acid bacteria producing superoxide dismutase. Am. J. Physiol. Gastrointest Liver Physiol., 294 (1): G353
64. Han, W., Mercenier, A., Ait-Belgnaoui, A., Pavan, S., Lamine, F., van Swam, I. I., Kleerebezem, M., Salvador-Cartier, C., Hisbergues, M., Bueno, L., Theodorou, V. and Fioramonti, J. 2006. Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm. Bowel. Dis., 12 (11): 1044-1052.
65. Harisa, G. I., Taha, E. I., Khalil, A. F. and Salem, M. M. 2009. Oral administration of Lactobacillus acidophilus restores nitric oxide level in diabetic rats. Aust. J. Basic Appl. Sci., 3 (3): 2963-2969.
66. Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B. and Drexler, H. 2003. Role of oxidative stress in atherosclerosis. Am. J. Cardiol., 91 (3 SUPPL. 1): 7-11.
67. Heilbronn, L. K. and Campbell, L. V. 2008. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr. Pharm. Design., 14: 1225-1230.
68. Higashi, Y., Noma, K., Yoshizumi, M. and Kihara, Y. 2009. Endothelial function and oxidative stress in cardiovascular diseases. Circ. J., 73 (3): 411-418.
69. Hill, A. M., Fleming, J. A. and Kris-Etherton, P. M. 2009. The role of diet and nutritional supplements in preventing and treating cardiovascular disease. Curr. Opin. Cardiol., 24 (5): 433-441.
70. Hlivak, P., Odraska, J., Ferencik, M., Ebringer, L., Jahnova, E. and Mikes, Z. 2005. One-year application of probiotic strain Enterococcus faecium M-74 decreases serum cholesterol levels. Bratisl. Lek. Listy., 106 (2): 67-72.
71. Hofmann, M. A., Lalla, E., Lu, Y., Gleason, M. R., Wolf, B. M., Tanji, N., Ferran, L. J., Kohl, B., Rao, V., Kisiel, W., Stern, D. M. and Schmidt, A. M. 2001. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest., 107 (6): 675-683.
72. Hooper, L. V., Midtvedt, T. and Gordon, J. I. 2002. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr., 22 (1): 283-307.
73. Hou, J. W., Yu, R. C. and Chou, C. C. 2000. Changes in some components of soymilk during fermentation with bifidobacteria. Food Res. Int., 33 (5): 393-397.
74. Hugenholtz, J., Hunik, J., Santos, H. and Smid, E. J. 2002. Nutraceutical production by propionibacteria. Lait., 82 (1): 103-112.
75. Ishikawa, H., Akedo, I., Umesaki, Y., Tanaka, R., Imaoka, A. and Otani, T. 2003. Randomized controlled trial of the effect of Bifidobacteria-fermented milk on ulcerative colitis. J. Am. Coll. Nutr., 22 (1): 56-63.
76. Isolauri, E., Rautanen, T., Juntunen, M., Sillanaukee, P. and Koivula, T. 1991. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics., 88 (1): 90-97.
77. Jarvenpaa, S., Tahvonen, R. L., Ouwehand, A. C., Sandell, M., Jarvenpaa, E. and Salminen, S. 2007. A probiotic, Lactobacillus fermentum ME-3, has antioxidative capacity in soft cheese spreads with different fats. J. Dairy Sci., 90 (7): 3171-3177.
78. Kalliomaki, M., Collado, M. C., Salminen, S. and Isolauri, E. 2008. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr., 87 (3): 534-538.
79. Kaur, I. P., Chopra, K. and Saini, A. 2002. Probiotics: Potential pharmaceutical applications. Eur. J. Pharm. Sci., 15 (1): 1-9.
80. Kawase, M., Hashimoto, H., Hosoda, M., Morita, H. and Hosono, A. 2000. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J. Dairy Sci., 83 (2): 255-263.
81. Kelly, D., Campbell, J. I., King, T. P., Grant, G., Jansson, E. A., Coutts, A. G. P., Pettersson, S. and Conway, S. 2004. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-[gamma] and RelA. Nat. Immunol., 5 (1): 104-112.
82. Korhonen, R., Korpela, R., Saxelin, M., Maki, M., Kankaanranta, H. and Moilanen, E. 2001. Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation., 25 (4): 223-232.
83. Kruis, W., Fric, P., Pokrotnieks, J., Lukas, M., Fixa, B., Kascak, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., Wolff, C. and Schulze, J. 2004. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut., 53 (11): 1617-1623.
84. Kullisaar, T., Songisepp, E., Mikelsaar, M., Zilmer, K., Vihalemm, T. and Zilmer, M. 2003. Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human subjects. Br. J. Nutr., 90: 449-456.
85. Kullisaar, T., Zilmer, M., Mikelsaar, M., Vihalemm, T., Annuk, H., Kairane, C. and Kilk, A. 2002. Two antioxidative lactobacilli strains as promising probiotics. Int. J. Food Microbiol., 72 (3): 215-224.
86. LeBlanc, J. G., del Carmen, S., Miyoshi, A., Azevedo, V., Sesma, F., Langella, P., Bermúdez-Humarán, L. G., Watterlot, L., Perdigon, G. and de Moreno de LeBlanc, A. 2011. Use of superoxide dismutase and catalase producing lactic acid bacteria in TNBS induced Crohn's disease in mice. J. Biotechnol., 151 (3): 287-293.
87. Lee, H. Y., Park, J. H., Seok, S. H., Baek, M. W., Kim, D. J., Lee, K. E., Paek, K. S., Lee, Y. and Park, J. H. 2006. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. BBA-Mol. Cell Biol. L., 1761 (7): 736-744.
88. Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D. and Gordon, J. I. 2005. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci., 102 (31): 11070-11075.
89. Ley, R. E., Turnbaugh, P. J., Klein, S. and Gordon, J. I. 2006. Microbial ecology: Human gut microbes associated with obesity. Nature., 444 (7122): 1022-1023.
90. Lin, M. Y. and Chang, F. J. 2000. Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig. Dis. Sci., 45 (8): 1617-1622.
91. Lin, M. Y. and Yen, C. L. 1999. Reactive oxygen species and lipid peroxidation product-scavenging ability of yogurt organisms. J. Dairy Sci., 82 (8): 1629-1634.
92. Lin, T. Y., Lin, C. W. and Wang, Y. J. 2003. Production of conjugated linoleic acid by enzyme extract of Lactobacillus acidophilus CCRC 14079. Food Chem., 83 (1): 27-31.
93. Liong, M. T. and Shah, N. P. 2005. Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J. Dairy Sci., 88 (1): 55-66.
94. Liu, A. H. and Leung, D. Y. M. 2006. Renaissance of the hygiene hypothesis. J. Allergy Clin. Immunol., 117 (5): 1063-1066.
95. Lund, B., Adamsson, I. and Edlund, C. 2002. Gastrointestinal transit survival of an Enterococcus faecium probiotic strain administered with or without vancomycin. Int. J. Food Microbiol., 77 (1-2): 109-115.
96. Macouzet, M., Lee, B. H. and Robert, N. 2009. Production of conjugated linoleic acid by probiotic Lactobacillus acidophilus La-5. J. Appl. Microbiol., 106 (6): 1886-1891.
97. Martin, F. P. J., Wang, Y., Sprenger, N., Yap, I. K. S., Lundstedt, T., Lek, P., Rezzi, S., Ramadan, Z., van Bladeren, P., Fay, L. B., Kochhar, S., Lindon, J. C., Holmes, E. and Nicholson, J. K. 2008. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol. Syst. Biol., 4: 157
98. Mater, D. D. G., Langella, P., Corthier, G. and Flores, M. J. 2005. Evidence of vancomycin resistance gene transfer between enterococci of human origin in the gut of mice harbouring human microbiota. J. Antimicrob. Chemother., 56 (5): 975-978.
99. Matsuzaki, T., Nagata, Y., Kado, S., Uchida, K., Hashimoto, S. and Yokokura, T. 1997a. Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice. Acta Pathol. Microbiol. Immunol. Scand., 105 (7-12): 637-642.
100. Matsuzaki, T., Nagata, Y., Kado, S., Uchida, K., Kato, I., Hashimoto, S. and Yokokura, T. 1997b. Prevention of onset in an insulin-dependent diabetes mellitus model, NOD mice, by oral feeding of Lactobacillus casei. Acta Pathol. Microbiol. Immunol. Scand., 105 (7-12): 643-649.
101. Matsuzaki, T., Yamazaki, R., Hashimoto, S. and Yokokura, T. 1997c. Antidiabetic effects of an oral administration of Lactobacillus casei in a non-insulin-dependent diabetes mellitus (NIDDM) model using KK-Ay mice. Endocr. J., 44 (3): 357-365.
102. McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Fekety, R., Elmer, G. W., Moyer, K. A., Melcher, S. A., Bowen, K. E., Cox, J. L., Noorani, Z., Harrington, G., Rubin, M. and Greenwald, D. 1994. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA., 271 (24): 1913-1918.
103. Meng, X. C., Stanton, C., Fitzgerald, G. F., Daly, C. and Ross, R. P. 2008. Anhydrobiotics: The challenges of drying probiotic cultures. Food Chem., 106 (4): 1406-1416.
104. Metchnikoff, E. 1907. The Prolongation of Life, London: William Heinemann.
105. Meyer, D. and Stasse-Wolthuis, M. 2009. The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur. J. Clin. Nutr., 63 (11): 1277-1289.
106. Mikelsaar, M. and Zilmer, M. 2009. Lactobacillus fermentum ME-3-an antimicrobial and antioxidative probiotic. Microb. Ecol. Health Dis., 21 (1): 1-27.
107. Mille, Y., Obert, J. P., Beney, L. and Gervais, P. 2004. New drying process for lactic bacteria based on their dehydration behavior in liquid medium. Biotechnol. Bioeng., 88 (1): 71-76.
108. Mohammad, M. A., Molloy, A., Scott, J. and Hussein, L. 2006. Plasma cobalamin and folate and their metabolic markers methylmalonic acid and total homocysteine among Egyptian children before and after nutritional supplementation with the probiotic bacteria Lactobacillus acidophilus in yoghurt matrix. Int. J. Food Sci. Nutr., 57 (7-8): 470-480.
109. Molina, V. C., Médici, M., Taranto, M. P. and De Valdez, G. F. 2009. Lactobacillus reuteri CRL 1098 prevents side effects produced by a nutritional vitamin B12 deficiency. J. Appl. Microbiol., 106 (2): 467-473.
110. Morishita, T., Tamura, N., Makino, T. and Kudo, S. 1999. Production of menaquinones by lactic acid bacteria. J. Dairy Sci., 82 (9): 1897-1903.
111. Morita, H., Toh, H., Fukuda, S., Horikawa, H., Oshima, K., Suzuki, T., Murakami, M., Hisamatsu, S., Kato, Y., Takizawa, T., Fukuoka, H., Yoshimura, T., Itoh, K., O'Sullivan, D. J., McKay, L. L., Ohno, H., Kikuchi, J., Masaoka, T. and Hattori, M. 2008. Comparative genome analysis of Lactobacillus reuteri and Lactobacillus fermentum reveal a genomic island for reuterin and cobalamin production. DNA Res., 15 (3): 151-161.
112. Naruszewicz, M., Johansson, M. L., Zapolska-Downar, D. and Bukowska, H. 2002. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am. J. Clin. Nutr., 76 (6): 1249-1255.
113. Nielsen, M. S., Martinussen, T., Flambard, B., Sørensen, K. I. and Otte, J. 2009. Peptide profiles and angiotensin-I-converting enzyme inhibitory activity of fermented milk products: Effect of bacterial strain, fermentation pH, and storage time. Int. Dairy J., 19 (3): 155-165.
114. Nishitani, Y., Tanoue, T., Yamada, K., Ishida, T., Yoshida, M., Azuma, T. and Mizuno, M. 2009. Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice. Int. Immunopharmacol., 9 (12): 1444-1451.
115. Nista, E. C., Candelli, M., Cremonini, F., Cazzato, I. A., Zocco, M. A., Franceschi, F., Cammarota, G., Gasbarrini, G. and Gasbarrini, A. 2004. Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: Randomized, double-blind, placebo controlled trial. Aliment. Pharmacol. Ther., 20 (10): 1181-1188.
116. Noh, D. O., Kim, S. H. and Gilliland, S. E. 1997. Incorporation of cholesterol into the cellular membrane of Lactobacillus acidophilus ATCC 43121. J. Dairy Sci., 80 (12): 3107-3113.
117. Olson, R. E. 1984. The function and metabolism of vitamin K. Annu. Rev. Nutr., 4 (1): 281-337.
118. Ouwehand, A. C., Kurvinen, T. and Rissanen, P. 2004. Use of a probiotic Bifidobacterium in a dry food matrix, an in vivo study. Int. J. Food Microbiol., 95 (1): 103-106.
119. Pawan, R. and Bhatia, A. 2007. Systemic immunomodulation and hypocholesteraemia by dietary probiotics: A clinical study. J. Clin. Diag. Res., 1 (6): 467-475.
120. Pompei, A., Cordisco, L., Amaretti, A., Zanoni, S., Matteuzzi, D. and Rossi, M. 2007. Folate production by bifidobacteria as a potential probiotic property. Appl. Environ. Microbiol., 73 (1): 179-185.
121. Pompei, A., Cordisco, L., Amaretti, A., Zanoni, S., Raimondi, S., Matteuzzi, D. and Rossi, M. 2007. Administration of folate-producing bifidobacteria enhances folate status in Wistar rats. J. Nutr., 137 (12): 2742-2746.
122. Power, D., Burton, J., Chilcott, C., Dawes, P. and Tagg, J. 2008. Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur. J. Clin. Microbiol., 27 (12): 1261-1263.
123. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., Yamada, T., Mende, D. R., Li, J., Xu, J., Li, S., Li, D., Cao, J., Wang, B., Liang, H., Zheng, H., Xie, Y., Tap, J., Lepage, P., Bertalan, M., Batto, J. M., Hansen, T., Le Paslier, D., Linneberg, A., Nielsen, H. B., Pelletier, E., Renault, P., Sicheritz-Ponten, T., Turner, K., Zhu, H., Yu, C., Li, S., Jian, M., Zhou, Y., Li, Y., Zhang, X., Li, S., Qin, N., Yang, H., Wang, J., Brunak, S., Dore, J., Guarner, F., Kristiansen, K., Pedersen, O., Parkhill, J., Weissenbach, J., Bork, P., Ehrlich, S. D. and Wang, J. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature., 464 (7285): 59-65.
124. Raoult, D. 2009. Probiotics and obesity: A link?. Nat. Rev. Micro., 7 (9): 616-616.
125. Reinhardt, C., Reigstad, C. S. and Bäckhed, F. 2009. Intestinal microbiota during infancy and its implications for obesity. J. Pediatr. Gastroenterol Nutr., 48 (3): 249-256.
126. Rochat, T., Bermudez-Humaran, L., Gratadoux, J. J., Fourage, C., Hoebler, C., Corthier, G. and Langella, P. 2007. Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice. Microb. Cell Fact., 6 (1): 22-32.
127. Rochat, T., Gratadoux, J.-J., Gruss, A., Corthier, G., Maguin, E., Langella, P. and van de Guchte, M. 2006. Production of a heterologous nonheme catalase by Lactobacillus casei: An efficient tool for removal of H2O2 and protection of Lactobacillus bulgaricus from oxidative stress in milk. Appl. Environ. Microbiol., 72 (8): 5143-5149.
128. Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., Kissela, B., Kittner, S., Lloyd-Jones, D., McDermott, M., Meigs, J., Moy, C., Nichol, G., O'Donnell, C., Roger, V., Sorlie, P., Steinberger, J., Thom, T., Wilson, M. and Hong, Y. 2008. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation., 117 (4): e25-e146.
129. Rossi, M., Amaretti, A. and Raimondi, S. 2011. Folate production by probiotic bacteria. Nutrients., 3 (1): 118-134.
130. Round, J. L. and Mazmanian, S. K. 2009. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol., 9 (5): 313-323.
131. Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., Karanja, N., Lin, P.-H. and DASH-Sodium Collaborative Research Group. 2001. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N. Engl. J. Med., 344 (1): 3-10.
132. Sane, D. C., Anton, L. and Brosnihan, K. B. 2004. Angiogenic growth factors and hypertension. Angiogenesis., 7 (3): 193-201.
133. Schultz, M., Strauch, U. G., Linde, H.-J., Watzl, S., Obermeier, F., Gottl, C., Dunger, N., Grunwald, N., Scholmerich, J. and Rath, H. C. 2004. Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin. Diagn. Lab. Immunol., 11 (2): 372-378.
134. Şengül, N., Aslím, B., Uçar, G., Yücel, N., Işi{dotless}k, S., Bozkurt, H., Sakaoǧullarí, Z. and Atalay, F. 2006. Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats. Dis. Colon Rectum., 49 (2): 250-258.
135. Seppo, L., Jauhiainen, T., Poussa, T. and Korpela, R. 2003. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr., 77 (2): 326-330.
136. Simons, L. A., Amansec, S. G. and Conway, P. 2006. Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr. Metab. Cardiovas., 16 (8): 531-535.
137. Sleator, R. D. and Hill, C. 2008. New frontiers in probiotic research. Lett. Appl. Microbiol., 46 (2): 143-147.
138. Sobko, T., Huang, L., Midtvedt, T., Norin, E., Gustafsson, L. E., Norman, M., Jansson, E. A. and Lundberg, J. O. 2006. Generation of NO by probiotic bacteria in the gastrointestinal tract. Free Radic. Biol. Med., 41 (6): 985-991.
139. Sokol, H., Arnaud-Pigneur, B., Watterlot, L., Lakhdari, O., Blottiere, H. M., Grangette, C., Trugnan, G., Dore, J. M., Thomas, G., Marteau, P. R., Seksik, P. and Langella, P. 2008. Counterbalancing dysbiosis in Crohn's disease: Faecalibacterium prausnitzii, a major commensal bacterium, exhibits in vitro and in vivo anti-inflammatory effects. Gastroenterology., 134 (4 SUPPL. 1): A-359.
140. Songisepp, E., Kals, J., Kullisaar, T., Mandar, R., Hutt, P., Zilmer, M. and Mikelsaar, M. 2005. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutr. J., 4 (1): 22
141. Songisepp, E., Kullisaar, T., Hutt, P., Elias, P., Brilene, T., Zilmer, M. and Mikelsaar, M. 2004. A new probiotic cheese with antioxidative and antimicrobial activity. J. Dairy Sci., 87 (7): 2017-2023.
142. Storz, G. and Imlay, J. A. 1999. Oxidative stress. Curr. Opin. Microbiol., 2 (2): 188-194.
143. Strachan, D. P. 1989. Hay fever, hygiene, and household size. Brit. Med. J., 299 (6710): 1259-1260.
144. Strain, J. J., Dowey, L., Ward, M., Pentieva, K. and McNulty, H. 2004. B-vitamins, homocysteine metabolism and CVD. Proc. Nutr. Soc., 63 (04): 597-603.
145. Strozzi, G. P. and Mogna, L. 2008. Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains. J. Clin. Gastroenterol., 42: S179-S184.
146. Sun, T., Zhao, S., Wang, H., Cai, C., Chen, Y. and Zhang, H. 2009. ACE-inhibitory activity and gamma-aminobutyric acid content of fermented skim milk by Lactobacillus helveticus isolated from Xinjiang koumiss in China. Eur. Food Res. Technol., 228 (4): 607-612.
147. Suzuki, M., Kamei, M., Itabe, H., Yoneda, K., Bando, H., Kume, N. and Tano, Y. 2007. Oxidized phospholipids in the macula increase with age and in eyes with age-related macular degeneration. Mol. Vis., 13: 772-778.
148. Sybesma, W., Burgess, C., Starrenburg, M., Sinderen, D. V. and Hugenholtz, J. 2004. Multivitamin production in Lactococcus lactis using metabolic engineering. Metab. Eng., 6 (2): 109-115.
149. Szajewska, H., Ruszczyn'ski, M. and Radzikowski, A. 2006. Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trials. J. Pediatr., 149 (3): 367-372.
150. Tabuchi, M., Ozaki, M., Tamura, A., Yamada, N., Ishida, T., Hosoda, M. and Hosono, A. 2003. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci. Biotech. Bioch., 67 (6): 1421-1424.
151. Taki, K., Takayama, F. and Niwa, T. 2005. Beneficial effects of bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients. J. Ren. Nutr., 15 (1): 77-80.
152. Tanida, M., Yamano, T., Maeda, K., Okumura, N., Fukushima, Y. and Nagai, K. 2005. Effects of intraduodenal injection of Lactobacillus johnsonii La1 on renal sympathetic nerve activity and blood pressure in urethane-anesthetized rats. Neurosci. Lett., 389 (2): 109-114.
153. Taranto, M. P., Vera, J. L., Hugenholtz, J., De Valdez, G. F. and Sesma, F. 2003. Lactobacillus reuteri CRL1098 produces cobalamin. J. Bacteriol., 185 (18): 5643-5647.
154. Teemu, H., Seppo, S., Jussi, M., Raija, T. and Kalle, L. 2008. Reversible surface binding of cadmium and lead by lactic acid and bifidobacteria. Int. J. Food Microbiol., 125 (2): 170-175.
155. Terpstra, A. H. 2004. Effect of conjugated linoleic acid on body composition and plasma lipids in humans: An overview of the literature. Am. J. Clin. Nutr., 79 (3): 352-361.
156. Tilg, H., Moschen, A. R. and Kaser, A. 2009. Obesity and the microbiota. Gastroenterology., 136 (5): 1476-1483.
157. Torres, M. A., Jones, J. D. G. and Dangl, J. L. 2006. Reactive oxygen species signaling in response to pathogens. Plant Physiol., 141 (2): 373-378.
158. Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R. and Gordon, J. I. 2007. The Human Microbiome Project. Nature., 449 (7164): 804-810.
159. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R. and Gordon, J. I. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature., 444 (7122): 1027-1031.
160. Veiga, P., Juste, C., Lepercq, P., Saunier, K., Beguet, F. and Gerard, P. 2005. Correlation between faecal microbial community structure and cholesterol-to-coprostanol conversion in the human gut. FEMS Microbiol. Lett., 242 (1): 81-86.
161. Victor, V., Rocha, M., Sola, E., Banuls, C., Garcia-Malpartida, K. and Hernandez-Mijares, A. 2009. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr. Pharm. Design., 15: 2988-3002.
162. Vijay-Kumar, M., Aitken, J. D., Carvalho, F. A., Cullender, T. C., Mwangi, S., Srinivasan, S., Sitaraman, S. V., Knight, R., Ley, R. E. and Gewirtz, A. T. 2010. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science., 328 (5975): 228-231.
163. Vincent, H. K., Innes, K. E. and Vincent, K. R. 2007. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes. Metab., 9 (6): 813-839.
164. Vinod, S., Kiran, S., Sarika, A., Desh Deepak, S., Parul, T., Ganda, L. S. and Hariom, Y. 2009. Innate and specific gut-associated immunity and microbial interference. FEMS Immunol. Med. Microbiol., 55 (1): 6-12.
165. Wang, K. Y., Li, S. N., Liu, C. S., Perng, D. S., Su, Y. C., Wu, D. C., Jan, C. M., Lai, C. H., Wang, T. N. and Wang, W. M. 2004. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am. J. Clin. Nutr., 80 (3): 737-741.
166. Wang, L., Manson, J. E., Buring, J. E., Lee, I. M. and Sesso, H. D. 2008. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension., 51 (4): 1073-1079.
167. Wang, Y., Xu, N., Xi, A., Ahmed, Z., Zhang, B. and Bai, X. 2009. Effects of Lactobacillus plantarum MA2 isolated from Tibet kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. Appl. Microbiol. Biot., 84 (2): 341-347.
168. Wang, Y. C., Yu, R. C. and Chou, C. C. 2006. Antioxidative activities of soymilk fermented with lactic acid bacteria and bifidobacteria. Food Microbiol., 23 (2): 128-135.
169. Wang, Y. W. and Jones, P. J. H. 2004. Conjugated linoleic acid and obesity control: Efficacy and mechanisms. Int. J. Obes. Relat. Metab. Disord., 28 (8): 941-955.
170. Watterlot, L., Rochat, T., Sokol, H., Cherbuy, C., Bouloufa, I., Lefèvre, F., Gratadoux, J.-J., Honvo-Hueto, E., Chilmonczyk, S., Blugeon, S., Corthier, G., Langella, P. and Bermúdez-Humarán, L. G. 2010. Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int. J. Food Microbiol., 144 (1): 35-41.
171. Wellen, K. E. and Hotamisligil, G. S. 2003. Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest., 112 (12): 1785-1788.
172. Wellen, K. E. and Hotamisligil, G. S. 2005. Inflammation, stress, and diabetes. J. Clin. Invest., 115 (5): 1111-1119.
173. Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., Gordon, J. I. and Chervonsky, A. V. 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature., 455 (7216): 1109-1113.
174. West, D. B., Delany, J. P., Camet, P. M., Blohm, F., Truett, A. A. and Scimeca, J. 1998. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am. J. Physiol., 275 (3): R667-R672.
175. WHO. 1999. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications, Geneva: Report of a World Health Organization consultation. World Health Organization.
176. WHO. 2000. Obesity: Preventing and Managing the Global Epidemic, Geneva: World Health Organization Technical Report Series 894. World Health Organization
177. Witztum, J. L. 1994. The oxidation hypothesis of atherosclerosis. Lancet., 344 (8925): 793-795.
178. Xiao, J. Z., Kondo, S., Takahashi, N., Miyaji, K., Oshida, K., Hiramatsu, A., Iwatsuki, K., Kokubo, S. and Hosono, A. 2003. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J. Dairy Sci., 86 (7): 2452-2461.
179. Yadav, H., Jain, S. and Sinha, P. R. 2007a. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition., 23 (1): 62-68.
180. Yadav, H., Jain, S. and Sinha, P. R. 2007b. Production of free fatty acids and conjugated linoleic acid in probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei during fermentation and storage. Int. Dairy J., 17 (8): 1006-1010.
181. Yamano, T., Tanida, M., Niijima, A., Maeda, K., Okumura, N., Fukushima, Y. and Nagai, K. 2006. Effects of the probiotic strain Lactobacillus johnsonii strain La1 on autonomic nerves and blood glucose in rats. Life Sci., 79 (20): 1963-1967.
182. Yea Ping, L., Carolyn, H. T., Jeremy, A. P., George, D. F. and James, V. 2008. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun. Inflamm. Bowel. Dis., 14 (8): 1068-1083.
183. Yoon, J. W. and Jun, H. S. 2005. Autoimmune destruction of pancreatic beta cells. Am. J. Ther., 12 (6): 580-591.